Tagged with clinical

Sweden In a fast-changing Nordic CRO industry, CTC Clinical Trial Consultants has opted to differentiate with a unique one-stop-shop approach. CEO Anders Millerhovf reveals how the relatively young company has managed to take over the Swedish scene. Moreover, he outlines the challenges faced by early clinical development and discusses the strategies…

Hungary Dr. György Blaskó, former President and Chairman of the Hungarian European Clinical Research Infrastructure Network, explains the role of the research network, the impact it has on the Hungarian clinical research environment, and the areas of improvement moving forward.   Domestic centralized health care and the presence of a single…

Thailand PharmaBoardroom’s latest report: Healthcare & Life Sciences Review: Thailand is available for download now.   Thailand is in the midst of an economic transformation with healthcare at its heart. With four years of around three-four percent annual GDP growth behind it, ASEAN’s second-largest economy has implemented an ‘Industry 4.0’ policy through which…

Hungary Dr. Zsuzsanna Fürst, President of the Ethics Committee for Clinical Pharmacology, elaborates on the role and activities of the ethics committee, shares her insights on structural framework of the application process for clinical trials, and the future outlook of clinical research in Hungary.   Each and every application,  both initial…

Puerto Rico Dr Amarilys Silva-Boschetti and Dr Miguel Vázquez-Padua of the Puerto Rico Consortium for Clinical Investigation (PRCCI) underline the various benefits for pharmaceutical, biotechnology and medtech companies to conduct clinical trials in Puerto Rico. They also highlight further steps of how the Consortium, which is part of the Puerto Rico Science,…

China Dr Irwin Wang, CEO of Reistone Biopharma, shares her motivations behind the establishment of the company, their extremely productive collaboration with Jiangsu Hengrui (China’s largest pharma company by market capitalization), and their exciting international clinical development strategy for their three assets.   I realized that if I wanted to establish…

Pharma Market Poland is by far the largest pharma market in the Central and Eastern Europe (CEE) region, with a total value of EUR 6.352 billion for 2017. The Czech Republic is in second place, followed by Romania and Hungary Made with Visme Infographic Maker     The CEE countries that exported…

Clinical Trials Hungary has long been one of the leading countries in Central and Eastern Europe for clinical trials. However, a downward trend in the number of research projects being conducted in the country since 2015 has some stakeholders concerned about the future of Hungary as a regional clinical trials hub.   …

Puerto Rico Merck (MSD outside of the USA) is celebrating its 70-year anniversary in Puerto Rico this year. Executive Managing Director Wendy Perry highlights the company’s extensive footprint on the island which includes commercial, manufacturing and clinical research operations. She stresses the importance of maintaining a strong commercial presence locally to address…

Thailand As Thailand’s focus has shifted towards R&D over the past few years, the number of in-country clinical trials being conducted has increased concurrently. From 2011 to 2016, Thailand conducted a total of 739 clinical trials, the largest number within the Southeast Asian region, followed by Singapore (610 trials) and Malaysia…

Taiwan James Chiu, GM of Fresenius Kabi Taiwan, discusses the affiliate’s portfolio offering of parenteral and enteral nutrition in Taiwan as well as its move towards biosimilars. In addition, Chiu highlights the importance of the Taiwanese affiliate to the Asia Pacific region, product developments locally, and partnerships with domestic players.  …

Taiwan Sheron Lin, president of Daiichi Sankyo Taiwan, elaborates on the affiliate’s tactical positioning in the region and a leading market for clinical trials and new product launches. Lin goes on to share her strategic priorities in carrying out the Japanese company’s global 2025 vision of transforming into an innovative oncology…